Spinal xanthomatosis: A variant of cerebrotendinous xanthomatosis

Brain

Volumn 122, Issue 8, 1999, Pages 1589-1595

  Verrips, A ^c   Lycklama A Nijeholt G J ^a   Barkhof, F ^a   Van Engelen, B G M ^d   Wesseling, P ^d   Luyten, J A F M ^d   Wevers, R A ^d   Stam, J ^b   Wokke, J H J ^b   Van Den Heuvel, L P W J ^d   Keyser, A ^d   Gabreels F J M ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

Cerebrotendinous xanthomatosis; MRI; Myelopathy; Pathology

Indexed keywords

MYELIN;

ARTICLE; AUTOPSY; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL ARTICLE; DEMYELINATION; GENOTYPE; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL XANTHOMATOSIS; WHITE MATTER;

ADULT; AGE OF ONSET; CEREBELLUM; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; EXONS; FEMALE; GENOTYPE; HUMANS; INTRONS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POINT MUTATION; SPINAL CORD; SPINAL CORD DISEASES; STEROID HYDROXYLASES; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 0032815984     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.8.1589     Document Type: Article

References (37)

1. Batta AK, Shefer S, Batta M, Salen G. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. J Lipid Res 1985; 26: 690-8.
2. Bencze KS, Vande Polder DR, Prockop LD. Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 1990; 53: 166-7.
3. Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 1984; 311: 1649-52.
4. Björkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995. p. 2073-99.
5. Cali JJ, Russell DW. Characterization of human sterol 27-hydroxylase. J Biol Chem 1991a; 266: 7774-8.
6. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 1991b; 266: 7779-83.
7. Cruysberg JR, Wevers RA, Tolboom JJ. Juvenile cataract associated with chronic diarrhoea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol 1991; 112: 606-7.
8. Cruysberg JR, Wevers RA, van Engelen BG, Pinckers A, van Spreeken A, Tolboom JJ. Ocular and systemic manifestations of cerebrotendinous xanthomatosis [letter]. Am J Ophthalmol 1995; 120: 597-604.
9. Diedrich U, Ropte S. Cerebrotendinöse Xanthomatose: Beschreibung zweier Fälle und Differentialdiagnose zur Encephalomyelitis disseminata. Nervenarzt 1989; 60: 444-7.
10. Dotti MT, Federico A, Signorini E, Caputo N, Venturi C, Filosomi G, et al. Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings. [Review]. AJNR Am J Neuroradiol 1994; 15: 1721-6.
11. Elleder M, Michalec C, Jirasek A, Khun K, Havlova M, Ranny M. Membranocystic lesion in the brain in cerebrotendinous xanthomatosis. Histochemical and ultrastructural study with evidence of its ceroid nature. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 57: 367-74.
12. Garuti R, Lelli N, Barozzini M, Tiozzo R, Dotti MT, Federico A, et al. Cerebrotendinous xanthomatosis caused by two new mutations of the sterol-27-hydroxylase gene that disrupt mRNA splicing. J Lipid Res 1996; 37: 1459-67.
13. Guillain G, Bertrand I, Godet-Guillain J. Etude anatomo-clinique d'un cas de cholestérinose cérébrale. Rev Neurol (Paris) 1942; 74: 249-63.
14. Hokezu Y, Kuriyama M, Kubota R, Nakagawa M, Fujiyama J, Osame M. Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients. Neuroradiology 1992; 34: 308-12.
15. Koopman BJ, van der Molen JC, Wolthers BG, de Jager AE, Waterreus RJ, Gips CH. Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis). Clin Chim Acta 1984; 137: 305-15.
16. Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, et al. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. [Review]. J Neurol Sci 1991; 102: 225-32.
17. Lake B. Lysosomal and peroxisomal disorders. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Arnold; 1997. p. 657-753.
18. Luyten JA, Wenink PW, Steenbergen-Spanjers GC, Wevers RA, Ploos van Amstel HK, de Jong JG, et al. Metachromatic leukodystrophy: a 12-bp deletion in exon 2 of the arylsulfatase A gene in a late infantile variant. Hum Genet 1995; 96: 357-60.
19. Lycklama à Nijeholt GJ, Barkhof F, Castelijns JA, van Waesberghe JH, Valk J, Jongen PJ, et al. Comparison of two MR sequences for the detection of multiple sclerosis lesions in the spinal cord. AJNR Am J Neuroradiol 1996; 17: 1533-38.
20. Philippart M, Van Bogaert L. Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family. Arch Neurol 1969; 21: 603-10.
21. Pop PH, Joosten E, van Spreeken A, Gabreëls-Festen A, Jaspar H, ter Laak H, et al. Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol (Berl) 1984; 64: 259-64.
22. Reshef A, Meiner V, Berginer VM, Leitersdorf E. Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin. J Lipid Res 1994; 35: 478-83.
23. Restuccia D, Di Lazzaro V, Servidei S, Colosimo C, Tonali P. Somatosensory and motor evoked potentials in the assessment of cerebrotendinous xanthomatosis before and after treatment with chenodeoxycholic acid: a preliminary study. J Neurol Sci 1992; 112: 139-46.
24. Salen G, Meriwether TW, Nicolau G. Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis. Biochem Med 1975; 14: 57-74.
25. Schimschock JR, Alvord ECJ, Swanson PD. Cerebrotendinous xanthomatosis. Trans Am Neurol Assoc 1968; 93: 64-5
26. Schreiner A, Hopen G, Skrede S. Cerebrotendinous xanthomatosis (cholestanolosis). Investigations on two sisters and their family. Acta Neurol Scand 1975; 51: 405-16.
27. Soffer D, Benharroch D, Berginer V. The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol (Berl) 1995; 90: 213-20.
28. Stein W, Czuczwar S. W sprawie cholesterozy mozgowosciegnowej v. Bogaerta-Scherera-Epsteina. Neurologia Neurochir Psychiat Pol 1959; 9: 599-613.
29. Swartz M, Burman KD, Salen G. Cerebrotendinous xanthomatosis: a cause of cataracts and tendon xanthoma. Am J Med Sci 1982; 283: 147-52.
30. Thiébaut F. Paraplégie spasmodique et xanthomes tendineux associés. Des rapports de ce syndrome avec la cholestérinose cérébro-spinale. Rev Neurol 1942; 74: 313-5.
31. Tokimura Y, Kuriyama M, Arimura K, Fujiyama J, Osame M. Electrophysiological studies in cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 1992; 55: 52-5.
32. Van Bogaert L. Spinal cholesterolosis. Brain 1965; 88: 687-96.
33. Van Bogaert L, Scherer H, Epstein E. Une forme cérébrale de la cholestérinose généralisée. Paris: Masson; 1937.
34. Verrips A, Steenbergen-Spanjers GC, Luyten JA, van den Heuvel LP, Keyser A, Gabreëls FJ, et al. Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Hum Genet 1996; 98: 735-7.
35. Verrips A, Steenbergen-Spanjers GC, Luyten JA, Wevers RA, Wokke JH, Gabreëls FJ, et al. Exon skipping in the sterol 27-hydroxylase gene leads to cerebrotendinous xanthomatosis. Hum Genet 1997; 100: 284-6.
36. Verrips A, Wevers RA, Van Engelen BG, Keyser A, Wolthers BG, Barkhof F, et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism 1999; 48: 233-8.
37. Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Clin Chim Acta 1983; 131: 53-65.